ITP - ifosfamide, paclitaxel, and cisplatin; EP – etoposide/platinum; IA-EP – ifosfamide/Adriamycin-EP; Gem-FLP – gemcitabine, 5-FU, leucovorin, cisplatin. This is an ASCO Meeting Abstract from the ...

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

The impact of the Area Deprivation Index on immunotherapy outcomes in metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...

For patients undergoing prostate radiotherapy, acute toxicity is associated with late toxicity and decrement in qua ...

Proactive onco-coaching did not improve quality of life but was linked to better overall survival in patients with metastatic ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium, on February 13-15, 2025, in San Francisco, Calif. The ...

CHENGDU, China, Feb. 12, 2025 /PRNewswire/ -- At the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium 2025, to be held in San Francisco, USA, from Feb. 13-15, 2025, ...

Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) Cancers Symposium. The Dana-Farber led research exemplifies innovative and ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces presentations featuring the Company’s late-stage and next generation therapeutic programs at the upcoming ...